Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR9 | P51686 | 1/20 | 0.49 |
| ▸ | KMO | O15229 | 1/20 | 0.46 |
| ▸ | PTGDR2 | Q9Y5Y4 | 8/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3005494 | 0.87 | PTGDR2 (0.47) | KMOPTGDR2AKR1B1L3MBTL1GPR35 | |
| SCHEMBL16156180 | 0.84 | PTGDR2 (0.47) | PTGDR2AKR1B1 | |
| SCHEMBL12569581 | 0.82 | KDM4E (0.50) | CCR9KMOPTGDR2AKR1B1L3MBTL1 | |
| SCHEMBL3067363 | 0.81 | L3MBTL1 (0.64) | L3MBTL1CYP2C9KDM4EALDH1A1POLB | |
| SCHEMBL14564431 | 0.78 | KDM4E (0.49) | KMOPTGDR2AKR1B1L3MBTL1CYP2C9 | |
| SCHEMBL21335596 | 0.77 | MAPT (0.43) | CCR9CYP2C9KDM4EALDH1A1POLB | |
| SCHEMBL23502112 | 0.77 | KDM4E (0.38) | PTGDR2L3MBTL1GPR35KDM4E | |
| SCHEMBL21983450 | 0.75 | CYP1A2 (0.39) | CCR9KMOCYP2C9KDM4EALDH1A1 | |
| SCHEMBL6175115 | 0.75 | CCR9 (0.48) | CCR9PTGDR2AKR1B1GPR35CYP2C9 | |
| SCHEMBL1251025 | 0.74 | CCR2 (0.47) | L3MBTL1CYP2C9KDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104114169-A | Combination of CRTH2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis | ATOPIX THERAPEUTICS LTD | 2014-10-22 | — | — | CN | disclosed |